Improving the Efficacy of Doxorubicin by Using Artificial Nucleosides to Inhibit Translesion DNA Synthesis

Research output: Contribution to journalArticle

Original languageEnglish
JournalEuropean Journal of Hematology
StatePublished - 2020

Cite this